These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Prevention of succinylcholine fasciculations. Daley MD; Norman PH Can J Anaesth; 1998 Nov; 45(11):1131; author reply 1131-2. PubMed ID: 10021969 [No Abstract] [Full Text] [Related]
45. Myalgia and biochemical changes following intermittent suxamethonium administration. Effects of alcuronium, lignocaine, midazolam and suxamethonium pretreatments on serum myoglobin, creatinine kinase and myalgia. Laurence AS Anaesthesia; 1987 May; 42(5):503-10. PubMed ID: 3592177 [TBL] [Abstract][Full Text] [Related]
46. The effects of magnesium sulphate-pretreatment on suxamethonium-induced complications during induction of general endotracheal anaesthesia. Danladi KY; Sotunmbi PT; Eyelade OR Afr J Med Med Sci; 2007 Mar; 36(1):43-7. PubMed ID: 17876916 [TBL] [Abstract][Full Text] [Related]
47. The importance of activity and pretreatment in the prevention of suxamethonium myalgias. Oxorn DC; Whatley GS; Knox JW; Hooper J Br J Anaesth; 1992 Aug; 69(2):200-1. PubMed ID: 1389827 [TBL] [Abstract][Full Text] [Related]
48. Prevention of succinylcholine fasciculations. Kopman AF Can J Anaesth; 1998 Nov; 45(11):1130-1; author reply 1131-2. PubMed ID: 10021968 [No Abstract] [Full Text] [Related]